Nabla, which is one of the most widely adopted AI assistants in clinical care, announced it has raised $70 million in Series C funding. Led by HV Capital, with Highland Europe joining as key investor, DST Global, and existing investors Cathay Innovation and Tony Fadell’s Build Collective, this funding round brings Nabla’s total raise to $120 million.
The funding round also follows a wave of adoption across U.S. health systems, with Nabla’s AI assistant now embedded in more than 130 healthcare organizations, such as major academic medical centers, safety-net hospitals, community health centers, and physician groups nationwide. And now, Nabla is expanding beyond documentation into a more agentic model of clinical AI.
This next phase enhances clinical documentation integrity (CDI), initiates EHR actions, and adapts to support diverse clinical roles across care settings. By unifying ambient listening, dictation, coding, and command capabilities into a single, extensible, and agentic platform, Nabla is building toward its long-term vision: a proactive assistant that intuitively streamlines existing workflows.
Nabla’s assistant is now utilized by leading systems and providers, including CVS Health, Children’s Hospital Los Angeles, Carle Health, Denver Health, and the University of Iowa Health Care. Over the past year, adoption has surged across ambulatory, behavioral health, pediatric, and emergency settings, with early expansion into inpatient and nursing workflows underway. And Nabla is helping clinicians cut documentation time by more than half: peer-reviewed studies from the University of Iowa Health Care and real-world data from Denver Health confirm significant reductions in clinician burnout and a 15-point increase in patient satisfaction.
The company has increased its revenue by fivefold over the past six months and now supports over 85,000 clinicians and 20 million annual encounters. Designed for serving a broad range of care environments, Nabla’s assistant is available in 35 languages and is increasingly used in rural hospitals, Federally Qualified Health Centers (FQHCs), and children’s hospitals, where clinician time is stretched and operational efficiency is mission-critical. And the platform integrates with Epic, Cerner, athenahealth, NextGen, Greenway, and other major EHRs and is built on a privacy-first model.
Nabla is also a member of the Coalition for Health AI, helping to shape responsible AI governance in clinical care. At its core is a domain-specific large language model, refined over several years using clinically grounded data and a robust evaluation framework. And this foundation enables advanced customization without compromising accuracy. Nabla now processes more than 30 billion tokens each month, a scale that supports continuous refinement and delivers a measurable return on investment (ROI) for health systems.
With this new funding round, Nabla will build a comprehensive Adaptive Agentic Platform, accelerating product development:
— Proactive Coding Agent: Improving existing real-time support for ICD-10, HCC, and MCC coding, with upcoming features to guide E/M coding and surface compliance nudges.
— Context-Aware Agent: Building on existing support for patient summaries and pre-charting, Nabla is expanding its use of historical data to introduce smarter documentation, initiate orders, and direct EHR commands through an intuitive interface.
— Custom Care Setting Agent: Deploying new capabilities tailored for nurses, with early expansion into inpatient environments and other frontline roles.
How the funding will be used: The new funding round will be used to advance product development, fuel growth across Nabla’s technical, clinical, and go-to-market teams, and support strategic partnerships to expand into new care settings and deliver impact at a national scale.
KEY QUOTES:
“We’re going even deeper into clinical workflows while continuing to offer a highly customizable assistant that works across specialties. Clinicians already trust our accuracy and speed, and this funding allows us to expand that impact by embedding intelligent support directly into care delivery. We see a future where AI not only documents care, but actively drives efficiency by executing actions within complex clinical workflows and environments.”
Alex Lebrun, co-founder and CEO of Nabla
“Nabla stands out as a pioneer in clinical AI—not just for its bold vision, but for its enterprise-grade product and remarkable speed of execution. What Alex, Delphine, and Martin have built is nothing short of extraordinary. I’ve rarely seen a technology scale this quickly, earn this level of trust, and deliver such exceptional accuracy. Today, more than 130 Tier 1 healthcare organizations rely on Nabla, a testament to the team’s ability to pair technological excellence with deep empathy for clinicians. It’s a privilege to support this exceptional team on their mission to transform healthcare.”
Alexander Joel-Carbonell, Partner at HV Capital
“We’ve never seen a technology adopted like this across our organization. As an academic medical center, we serve a wide range of clinical needs. Nabla’s lightweight rollout made it easy for clinicians to start using it immediately. It fits cleanly into Epic and supports how our clinicians deliver care. What stands out just as much as the speed of adoption is the partnership. Nabla listens, adapts, and builds with us. That kind of collaboration drives meaningful change, and we’re excited for what’s ahead.”
Dr. James Blum, Chief Health Information Officer and Associate Professor of Anesthesiology, University of Iowa Physicians
